• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

369
65
48
46
18

COUNTRY

45
12
5
5
5

PRICE

296
549
1,011
1,445

PUBLISHED

79
124
495
1,445

PRODUCT TYPE

1,350
67
17
11

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE

Convulsions Global Clinical Trials Review, H1, 2014

Convulsions Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Convulsions Global Clinical Trials Review, H1, 2014" provides data on the Convulsions clinical trial scenario....

June 2014
FROM

Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014

Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014" provides data on the Dysgeusia...

June 2014
FROM

Fibromyalgia Global Clinical Trials Review, H1, 2014

Fibromyalgia Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Fibromyalgia Global Clinical Trials Review, H1, 2014" provides data on the Fibromyalgia clinical trial scenario....

June 2014
FROM

Cognitive Impairment Global Clinical Trials Review, H1, 2014

Cognitive Impairment Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Cognitive Impairment Global Clinical Trials Review, H1, 2014" provides data on the Cognitive Impairment...

June 2014
FROM

OpportunityAnalyzer: Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2018 Summary Amyotrophic lateral sclerosis (ALS) is a rare, but fatal, motor neuron disease (MND) characterized...

June 2014
FROM

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014" provides data on the Diabetic...

June 2014
FROM

Dementia Associated With Alzheimer's Disease Global Clinical Trials Review, H1, 2014

Dementia Associated With Alzheimer’s Disease Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Dementia Associated With Alzheimer’s Disease Global Clinical Trials Review,...

June 2014
FROM

Neuropathic Pain Global Clinical Trials Review, H1, 2014

Neuropathic Pain Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Neuropathic Pain Global Clinical Trials Review, H1, 2014" provides data on the Neuropathic Pain clinical...

June 2014
FROM

Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2014

Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Cognitive Impairment Associated With Schizophrenia (CIAS) Global...

June 2014
FROM

Brain Injury - Pipeline Review, H1 2014

Brain Injury - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Brain Injury - Pipeline Review, H1 2014’, provides an overview of the Brain Injury’s therapeutic pipeline. This report provides...

June 2014
FROM

Tauopathies - Pipeline Review, H1 2014

Tauopathies - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Tauopathies - Pipeline Review, H1 2014’, provides an overview of the Tauopathies’s therapeutic pipeline. This report provides...

June 2014
FROM

Japanese Encephalitis - Pipeline Review, H1 2014

Japanese Encephalitis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Japanese Encephalitis - Pipeline Review, H1 2014’, provides an overview of the Japanese Encephalitis’s therapeutic...

June 2014
FROM

Hyperalgesia - Pipeline Review, H1 2014

Hyperalgesia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hyperalgesia - Pipeline Review, H1 2014’, provides an overview of the Hyperalgesia’s therapeutic pipeline. This report provides...

June 2014
FROM
Inhaled CNS Therapeutics Inhaled CNS Therapeutics - Product Thumbnail Image

Inhaled CNS Therapeutics

Neurological disorders are highly prevalent worldwide And while mental and neurological disorders are responsible for about one per cent of deaths, they account for almost 11 per cent of disease burden...

June 2014
FROM

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD...

May 2014
FROM

Amnesia Global Clinical Trials Review, H1, 2014

Amnesia Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Amnesia Global Clinical Trials Review, H1, 2014" provides data on the Amnesia clinical trial scenario. This report...

May 2014
FROM

Ataxia Global Clinical Trials Review, H1, 2014

Ataxia Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Ataxia Global Clinical Trials Review, H1, 2014" provides data on the Ataxia clinical trial scenario. This report...

May 2014
FROM

AIDS Associated Dementia Global Clinical Trials Review, H1, 2014

AIDS Associated Dementia Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “AIDS Associated Dementia Global Clinical Trials Review, H1, 2014" provides data on the AIDS Associated...

May 2014
FROM

Autism Global Clinical Trials Review, H1, 2014

Autism Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Autism Global Clinical Trials Review, H1, 2014" provides data on the Autism clinical trial scenario. This report...

May 2014
FROM

Cerebral Infarction (Brain Infarction) - Pipeline Review, H1 2014

Cerebral Infarction (Brain Infarction) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cerebral Infarction (Brain Infarction) - Pipeline Review, H1 2014’, provides an overview of the...

May 2014
FROM
Loading Indicator

Our Clients

Our clients' logos